Posted by Michael Wonder on 03 Sep 2024
Vadadustat for symptomatic anaemia due to chronic kidney disease: missed opportunity
2 September 2024 - In the two manufacturer studies, important patient-relevant outcomes were not recorded.
It therefore remains unclear how seriously ill people fare under the new therapy.
